Characterization and evaluation of triamcinolone, raloxifene, and their dual-loaded microspheres as prospective local treatment system in rheumatic rat joints.
暂无分享,去创建一个
S. Ozen | D. Keskin | B. Kurum | S. Karahan | A. Tezcaner | Yigit Ocal
[1] D. Keskin,et al. Potential of Raloxifene in reversing osteoarthritis-like alterations in rat chondrocytes: An in vitro model study , 2013, Journal of Biosciences.
[2] M. Chauhan,et al. Intra-articular delivery of genipin cross-linked chitosan microspheres of flurbiprofen: preparation, characterization, in vitro and in vivo studies. , 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[3] G. Aldini,et al. Methylprednisolone-loaded PLGA microspheres: a new formulation for sustained release via intra-articular administration. A comparison study with methylprednisolone acetate in rats. , 2011, Journal of pharmaceutical sciences.
[4] A. Saraux,et al. Use of glucocorticoids in rheumatoid arthritis - pratical modalities of glucocorticoid therapy: recommendations for clinical practice based on data from the literature and expert opinion. , 2010, Joint, bone, spine : revue du rhumatisme.
[5] K. Avgoustakis,et al. Development of Biodegradable Controlled Release Scleral Systems of Triamcinolone Acetonide , 2010, Current eye research.
[6] E. Doelker,et al. Intra-articular drug delivery systems for the treatment of rheumatic diseases: a review of the factors influencing their performance. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[7] P. Stadelmann,et al. Dexamethasone-containing biodegradable superparamagnetic microparticles for intra-articular administration: physicochemical and magnetic properties, in vitro and in vivo drug release. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[8] D. Bikiaris,et al. Novel Biodegradable Polyesters. Synthesis and Application as Drug Carriers for the Preparation of Raloxifene HCl Loaded Nanoparticles , 2009, Molecules.
[9] S. Jacobsen,et al. Intra-articular depot formulation principles: role in the management of postoperative pain and arthritic disorders. , 2008, Journal of pharmaceutical sciences.
[10] Shengrong Guo,et al. Formation mechanism and release behavior of poly(epsilon-caprolactone) microspheres containing disodium norcantharidate. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[11] M. Lagerquist,et al. Long‐term anti‐arthritic and anti‐osteoporotic effects of raloxifene in established experimental postmenopausal polyarthritis , 2008, Clinical and experimental immunology.
[12] M. Lagerquist,et al. Role of raloxifene as a potent inhibitor of experimental postmenopausal polyarthritis and osteoporosis. , 2007, Arthritis and rheumatism.
[13] Zhao-yi Yang,et al. Validation of a Novel HPLC Method for the Determination of Raloxifene and Its Pharmacokinetics in Rat Plasma , 2007 .
[14] F. Otero-Espinar,et al. Effect of formulation variables on the prediction of release from microparticles with experimental design , 2006 .
[15] Greg Nalbandian and Susan Kovats. Estrogen, Immunity & Autoimmune Disease , 2005 .
[16] N. Ilowite,et al. Comparison of the intraarticular effectiveness of triamcinolone hexacetonide and triamcinolone acetonide in treatment of juvenile rheumatoid arthritis. , 2004, The Journal of rheumatology.
[17] R. Kaushik,et al. Poly-ϵ-caprolactone microspheres and nanospheres: an overview , 2004 .
[18] M. Maricic,et al. Skeletal and nonskeletal effects of raloxifene , 2003, Current osteoporosis reports.
[19] H. Carlsten,et al. Effects of raloxifene, a selective estrogen receptor modulator, on thymus, T cell reactivity, and inflammation in mice. , 2000, Cellular immunology.
[20] M. Østergaard,et al. Intra-Articular Corticosteroids in Arthritic Disease , 1998, BioDrugs.
[21] A. Stirling,et al. Pain relief in the rheumatoid knee after steroid injection. A single-blind comparison of hydrocortisone succinate, and triamcinolone acetonide or hexacetonide. , 1994, British journal of rheumatology.
[22] Nicholas A. Peppas,et al. A simple equation for description of solute release I. Fickian and non-fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs , 1987 .
[23] H. Möllmann,et al. Pharmacokinetics and pharmacodynamics of glucocorticoid suspensions after intra‐articular administration , 1986, Clinical pharmacology and therapeutics.
[24] R. P. Cumming. INTRA-ARTICULAR THERAPY , 1980, The Lancet.
[25] Yingjun Wang,et al. Drug distribution within poly(ɛ-caprolactone) microspheres and in vitro release , 2009 .
[26] M. Ahmed,et al. Characterization of polymeric poly(epsilon-caprolactone) injectable implant delivery system for the controlled delivery of contraceptive steroids. , 2006, Journal of biomedical materials research. Part A.
[27] S. Mcphee,et al. Current Medical Diagnosis and Treatment , 2009, Journal of Nuclear Medicine.